Protective effect and mechanism of low P50 haemoglobin oxygen carrier on isolated rat heart

References

• Slottosch I, Liakopoulos O, Kuhn E, et al. Controlled lung reperfusion to reduce pulmonary ischaemia/reperfusion injury after cardiopulmonary bypass in a porcine model. Interact Cardiovasc Thorac Surg. 2014;19(6):121–970.
   PubMed Web of Science ®Google Scholar
• Guo J, Wang SB, Yuan TY, et al. Coptisine protects rat heart against myocardial ischemia/reperfusion injury by suppressing myocardial apoptosis and inflammation. Atherosclerosis. 2013;231(2):384–391.
   PubMed Web of Science ®Google Scholar
• You Z, Li Q, Li B, et al. Isovolemic hemodilution with glutaraldehyde-polymerized human placenta hemoglobin (PolyPHb) attenuated rat liver ischemia/reperfusion injury. Artif Cells Nanomed Biotechnol. 2014;42(2):83–87.
   PubMed Web of Science ®Google Scholar
• Chang TMS. Blood replacement with nanobiotechnologically engineered hemoglobin and hemoglobin nanocapsules. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010;2(4):418–430.
   PubMed Web of Science ®Google Scholar
• Caswell JE, Strange MB, Rimmer DM, III, et al. A novel hemoglobin-based blood substitute protects against myocardial reperfusion injury. Am J Physiol-Heart Circ Physiol. 2005;288(4):H1796–1801.
   PubMed Web of Science ®Google Scholar
• Li T, Li J, Liu J, et al. Polymerized placenta hemoglobin attenuates ischemia/reperfusion injury and restores the nitroso-redox balance in isolated rat heart. Free Radic Biol Med. 2009;46(3):397–405.
   PubMed Web of Science ®Google Scholar
• Natanson C, Kern SJ, Lurie P, et al. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA. 2008;299(19):2304–2312.
   PubMed Web of Science ®Google Scholar
• Silverman TA, Weiskopf RB. Hemoglobin-based oxygen carriers: current status and future directions. Transfusion. 2009;49(11):2495–2515.
   PubMed Web of Science ®Google Scholar
• Zhou W, Zhao L, Wang J, et al. An optimal polymerization conditions for poly-human placenta hemoglobin with lower mean molecular weight. Artif Cells Nanomed Biotechnol. 2013;41(5):289–292.
   PubMed Web of Science ®Google Scholar
• García-Ruiz JM, Galán-Arriola C, Fernández-Jiménez R, et al. Bloodless reperfusion with the oxygen carrier HBOC-201 in acute myocardial infarction: a novel platform for cardioprotective probes delivery. Basic Res Cardiol. 2017;112(2):17–17.
   PubMed Web of Science ®Google Scholar
• Meng F, Kassa T, Jana S, et al. Comprehensive biochemical and biophysical characterization of hemoglobin-based oxygen carrier therapeutics: all HBOCs are not created equally. Bioconjug Chem. 2018;29(5):1560–1575.
   PubMed Web of Science ®Google Scholar
• Alayash AI. Mechanisms of toxicity and modulation of hemoglobin-based oxygen carriers (HBOCs). Shock. 2019;52(1S):41–49.
   PubMedGoogle Scholar
• Li T, Yang G, Zhu Y, et al. Beneficial effects of novel cross-linked hemoglobin YQ23 on hemorrhagic shock in rats and pigs. J Surg Res. 2017;210:213–222.
   PubMed Web of Science ®Google Scholar
• Kuang L, Zhu Y, Zhang J, et al. A novel cross-linked haemoglobin-based oxygen carrier is beneficial to sepsis in rats. Artif Cells Nanomed Biotechnol. 2019;47(1):1496–1504.
   PubMed Web of Science ®Google Scholar
• Edmondson M, Jana S, Meng F, et al. Redox states of hemoglobin determine left ventricle pressure recovery and activity of mitochondrial complex IV in hypoxic rat hearts. Free Radic Biol Med. 2019;141:348–361.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang Y, Deng Y, et al. Polymerized human placenta haemoglobin attenuates myocardial injury and aortic endothelial dysfunction in a rat model of severe burns. Artif Cells Nanomed Biotechnol. 2018;46(6):1141–1145.
   PubMed Web of Science ®Google Scholar
• Wang Q, Hu L, Hu Y, et al. Carbon monoxide-saturated hemoglobin-based oxygen carriers attenuate high-altitude-induced cardiac injury by amelioration of the inflammation response and mitochondrial oxidative damage. Cardiology. 2017;136(3):180–191.
   PubMed Web of Science ®Google Scholar
• Pan YL, Han ZY, He SF, et al. miR-133b-5p contributes to hypoxic preconditioning-mediated cardioprotection by inhibiting the activation of caspase-8 and caspase-3 in cardiomyocytes. Mol Med Rep. 2018;17(5):7097–7104.
   PubMed Web of Science ®Google Scholar
• Li H, Lv B, Kong L, et al. Nova1 mediates resistance of rat pheochromocytoma cells to hypoxia-induced apoptosis via the Bax/Bcl-2/caspase-3 pathway. Int J Mol Med. 2017;40(4):1125–1133.
   PubMed Web of Science ®Google Scholar
• Owumi SE, Dim UJ. Manganese suppresses oxidative stress, inflammation and caspase-3 activation in rats exposed to chlorpyrifos. Toxicol Rep. 2019;6:202–209.
   PubMed Web of Science ®Google Scholar
• Khafaga AF, El-Sayed YS. All-trans-retinoic acid ameliorates doxorubicin-induced cardiotoxicity: in vivo potential involvement of oxidative stress, inflammation, and apoptosis via caspase-3 and p53 down-expression. Naunyn Schmiedebergs Arch Pharmacol. 2018;391(1):59–70.
   PubMed Web of Science ®Google Scholar